Filter
1273
Text search:
drug
reaction
Featured
159
368
Language
Document type
853
182
106
57
23
21
20
4
4
2
1
Countries / Regions
92
38
34
34
33
30
30
28
25
23
23
22
18
16
15
15
15
15
13
12
12
11
10
10
9
9
9
8
8
8
7
6
6
6
5
5
4
4
4
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
510
184
46
38
30
24
13
Toolboxes
140
115
113
75
59
55
39
30
29
28
21
14
9
8
8
8
8
7
7
6
5
2
2
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Curriculum reform efforts to enhance training on rational medicine use (RMU) and AMR should pay particular attention to ensuring that the right topics are integrated and the right teaching-learning methodologies are adopted.
Third Edition: Revised October 2012
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.